4
Changes in Ownership
Spero Therapeutics, Inc. Filed Acc 0000950170-24-125339
CFO & CBO sold 40,596 shares at an average $1.31 ($53,008)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rajavelu Esther CFO & CBO | 2024-11-07 | Sale | −23,351 | $1.31 | $30,590 | 396,515 | D |
| Rajavelu Esther CFO & CBO | 2024-11-08 | Sale | −17,245 | $1.30 | $22,419 | 379,270 | D |
| Open-market sales · 40,596 sh · avg $1.31 · $53,008 | |||||||
Loading xslF345X05/ownership.xml…